Skye Bioscience SKYE
NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST

Skye Bioscience (SKYE) Change in Acquisitions & Divestments (2025 - 2026)

Updated

Skye Bioscience (SKYE) recorded Change in Acquisitions & Divestments of -$6.96 million in Q2 2026, compared with $11.94 million a year earlier.

Analysis

Skye Bioscience (SKYE) Change in Acquisitions & Divestments (2025 - 2026) Analysis & Trends

On a TTM basis, Skye Bioscience's Change in Acquisitions & Divestments came in at $6.89 million as of Jun 30, 2026.

  • Quarterly Change in Acquisitions & Divestments has ranged from -$10.9 million in Q1 2026 to $12.8 million in Q1 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Skye Bioscience 5.38 Mn -52.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.00 Mn
Jun 30, 2026 6.96 Mn
Mar 31, 2026 10.90 Mn
Jun 30, 2025 -11.94 Mn
Mar 31, 2025 -12.80 Mn
API Access

Skye Bioscience Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=SKYE&period=max&api_key=YOUR_API_KEY